ANGELICA DIAZ, NP-C
Family Nurse Practitioner · BELLAIRE, TX
Individual Active NPI 1073154209
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 494 | 157,378 | $12,590,566 | $3,976,252 | $3,165,295 |
| 2023 | 436 | 92,450 | $10,957,717 | $3,347,836 | $2,663,411 |
| 2022 | 146 | 19,640 | $2,307,814 | $663,452 | $528,620 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J0174 | Injection, lecanemab-irmb, 1 mg | 49,900 | $1 | $1 |
| J3111 | Injection, romosozumab-aqqg, 1 mg | 30,450 | $11 | $8 |
| J0897 | Injection, denosumab, 1 mg | 7,440 | $25 | $20 |
| J2182 | Injection, mepolizumab, 1 mg | 4,200 | $30 | $24 |
| J3245 | Injection, tildrakizumab, 1 mg | 2,300 | $136 | $108 |
| J2357 | Injection, omalizumab, 5 mg | 1,635 | $38 | $30 |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 1,590 | $31 | $25 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 1,009 | $0 | $0 |
| J0517 | Injection, benralizumab, 1 mg | 660 | $165 | $131 |
| 96372 | Injection of drug or substance under skin or into muscle | 585 | $12 | $10 |
| J3489 | Injection, zoledronic acid, 1 mg | 235 | $7 | $4 |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 208 | $52 | $41 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Family Nurse Practitioner | 363LF0000X | ✓ | AP144942 | TX |
| Registered Nurse | 163W00000X | 887268 | TX |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- No
Other Family Nurse Practitioner providers in Texas
- NPI 1629472873
- NPI 1073094165
- NPI 1407295058
- NPI 1720441561
- NPI 1154387702
- NPI 1629838958
- NPI 1801292313
- NPI 1578966388
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.